Prokidney Corp.
PROK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850270
In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Prokidney Corp. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 65 | 2 | 71 | +8 |
| Shares | 40.2M | 3.70M | 49.1M | +12.7M (+34.8%) |
| Value | $98.8M | $9.10M | $94.3M | +$4.65M (+5.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Prokidney Corp. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 6,413,690 | $12.3M | 0.00% |
| Renaissance Technologies LLC | 46,200 | $88.7K | 0.00% |
| Caption Management, LLC | 45,000 | $86.4K | 0.01% |
| D. E. Shaw & Co., Inc. | 40,301 | $77.4K | 0.00% |
| Castleview Partners, LLC | 32,921 | $63.2K | 0.04% |
| Virtus Family Office LLC | 27,500 | $52.8K | 0.07% |
| Intech Investment Management LLC | 24,075 | $46.2K | 0.00% |
| XTX Topco Ltd | 21,267 | $40.8K | 0.00% |
| ProShare Advisors LLC | 19,629 | $37.7K | 0.00% |
| EntryPoint Capital, LLC | 16,998 | $32.6K | 0.02% |
| Balyasny Asset Management LLC | 12,578 | $24.1K | 0.00% |
| HSBC Holdings PLC | 12,577 | $24.0K | 0.00% |
| Virtu Financial LLC | 10,458 | $20.0K | 0.00% |
| Capital Performance Advisors LLP | 279 | $536 | 0.00% |
| Sterling Capital Management LLC | 94 | $180 | 0.00% |
| Foster Dykema Cabot & Partners, LLC | 54 | $104 | 0.00% |
| Hemington Wealth Management | 99 | $0 | 0.00% |
Sold out (9)
Institutions that held Prokidney Corp. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Millennium Management LLC | 91,873 | $226.0K |
| Marshall Wace, LLP | 50,242 | $123.6K |
| Mirabella Financial Services LLP | 40,045 | $98.5K |
| Tudor Investment Corp Et Al | 30,484 | $75.0K |
| Federated Hermes, Inc. | 23,303 | $57.3K |
| Schonfeld Strategic Advisors LLC | 11,800 | $29.0K |
| The PNC Financial Services Group, Inc. | 672 | $1.65K |
| IFP Advisors, Inc | 20 | $49 |
| Northwestern Mutual Wealth Management Co | 2 | $5 |
Not filed for Q3 2024 yet (2)
Institutions that held Prokidney Corp. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,656,276 | $8.99M |
| Susquehanna Fundamental Investments, LLC | 42,990 | $105.8K |